Follow

Submissions from 2017

Link

Update on Novel Agents in Prostate Cancer, Elisabeth I. Heath, MD, FACP

Link

Increasing melanoma prevention through feedback of MC1R genotype, Peter A. Kanetsky, PhD, MPH

Link

Genetics Ancestry and Cancer Health Disparities, Camille Ragin, MPH, PHD

Link

Bridging the Gap between Patient-Centered Care and Evidence-Based Medicine: How and Why Communication Matters, Debra Roter, DrPH

Link

The Long Journey to Health Equity in America, Louis W. Sullivan, MD

Link

Clinical Research Networks: Strategies in Community-Academic Partnerships, Jake Vinson

Submissions from 2016

PDF

Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells., Marco Fiorillo, Rebecca Lamb, Herbert B Tanowitz, Luciano Mutti, Marija Krstic-Demonacos, Anna Rita Cappello, Ubaldo E. Martinez-Outshoorn, Federica Sotgia, and Michael P Lisanti

Link

Clinical Cancer Genetics: New Opportunities and Challenges, Judy E. Garber, MD, MPH

PDF

IDO1 is an Integral Mediator of Inflammatory Neovascularization., Arpita Mondal, Courtney Smith, James B. DuHadaway, Erika Sutanto-Ward, George C. Prendergast, Arturo Bravo-Nuevo, and Alexander J. Muller

Link

Recent 'advances' in breast and ovarian cancer genetics, Katherine L. Nathanson, MD

PDF

Cancer stem cell metabolism., Maria Peiris-Pagès, Ubaldo E. Martinez-Outshoorn, Richard G. Pestell, Federica Sotgia, and Michael P Lisanti

PDF

Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2., Beatrice Riva, Marco De Dominici, Ilaria Gnemmi, Samanta A. Mariani, Alberto Minassi, Valentina Minieri, Paolo Salomoni, Pier Luigi Canonico, Armando A Genazzani, Bruno Calabretta, and Fabrizio Condorelli

Link

Genetic Susceptibility to Epithelial Ovarian Cancer: Progress and Translational Potential, Thomas A. Sellers, PhD, MPH

PDF

Prolonged Morphine Exposure Induces Increased Firm Adhesion in an in Vitro Model of the Blood-Brain Barrier., Marianne Strazza, Vanessa Pirrone, Brian Wigdahl, Will Dampier, Wei Lin, Rui Feng, Monique E Maubert, Babette Weksler, Ignacio A Romero, Pierre-Olivier Couraud, and Michael R Nonnemacher

Link

Rethinking Our Roles in Good Dying, Carol Taylor, PhD, MSN, RN

Submissions from 2015

Link

Soft Tissue Sarcoma: Overview of Management, John A. Abraham, MD

Link

Personalized Medicine for Patients with Lymphoma, James Armitage, MD

PDF

Comparison of survival in patients with T cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease., Amer Beitinjaneh, Rima M. Saliba, L. Jeffrey Medeiros, Francesco Turturro, Gabriela Rondon, Martin Korbling, Luis Fayad, Michelle A. Fanale, Amin M. Alousi, Paolo Anderlini, Oran Betul, Uday R. Popat, Barbara Pro, and Issa F. Khouri

Link

Challenges and Opportunities at the Cancer/Aging Interface, Harvey Jay Cohen, MD

Link

Multi-level perspectives on optimizing the quality of colorectal cancer screening, Chyke A. Doubeni, MD, MPH, FRCS

PDF

PKCε Is an Essential Mediator of Prostate Cancer Bone Metastasis., Alvaro Gutierrez-Uzquiza, Cynthia Lopez-Haber University of Pennsylvania, Danielle L. Jernigan, Alessandro Fatatis, and Marcelo G. Kazanietz

Link

Has Genomic Sequencing of Pancreatic Cancers held the field back?, Benjamin E. Leiby, MD

Link

Precision Medicine in Colorectal Cancer: Molecular Factors to Optimize Systemic Therapeutic Decisions and Patient Care, Edith P. Mitchell, MD, FACP

Link

Achieving Health Equity addressing RACISM and other systems of structured inequity, Camara Phyllis Jones, MD, MPH, PhD

Link

Prostate Cancer Disparities: From Nucleotide to Neighborhood, Timothy R. Rebbeck, PhD

Link

Shifting the Prostate Cancer Drug Development Paradigm from Palliation to Cure, Howard I. Scher, MD

Submissions from 2014

PDF

Measuring Patient Satisfaction in Multidisciplinary Cancer Centers: Optimize Use of Results to Effect Change and Improve Processes, Mary-Kate Cellmer, BS

Link

Achieving Health Equity: Where does the Health Care's System's Responsibility End?, Karen M. Emmons, PhD

Link

Immature myeloid cells and skin tumor development, Dmitry Gabrilovich

Link

Transplantation for Myeloma-Still Relevant?, Parameswaran Hari, MD

Link

Isoprenoids and Cancer, Raymond J. Hohl, MD, PhD

Link

Thermal Oncology: The Evolving Role of Heat in Multidisciplinary Cancer Care, Mark Hurwitz, MD

Link

An Epigenetic Clock of Lifespan and Cancer, Jean-Pierre Issa, MD

Link

Management of Locally Advanced NSCLC: 25 Years in the Trenches, Corey J. Langer, MD, FACP

Link

The AML Genome(s), Timothy J. Ley, MD

Link

Molecular Landscaping of AML: Are we relearning the Past or Informing the Future?, Guido Marcucci, MD

Link

Navigating the Complex World of Cancer Diagnosis and Care: Minimizing Disparities, Edith Peterson Mitchell, MD, FACP

Link

Advances in Cutaneous Lymphomas: A Multidisciplinary Approach, Barbara Pro, MD

Link

Discovery of New Therapeutic Targets for Prostate Cancer, Owen N. Witte, MD

Submissions from 2013

Link

Genomic Guided Therapy in Cancer Patients, Robert B. Diasio, MD

Link

A 2-Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation, Neal Flomenberg, MD and Dolores Grosso, DNP

Link

Moving Beyond the PSA Controversy: Prostate Screening Controversy and Newer Tests for Prostate Cancer, Leonard G. Gomella

Link

Advances in Non-Small Cell Lung Cancer 2014, Thomas J. Lynch, Jr., MD

Link

A Translational Investigation of Cancer Metastasis, Zhang Ning

Link

Cell Cycle Control of Genomic Signaling, Richard Pestell

Link

Therapeutic Targeting of EMT in Prostate Cancer, Robert R. Reiter, MD, MBA

Link

A circulating free DNA assay, cMethDNA, in serum for detection of metastatic breast cancer and prediction of response to therapy, Sara Sukumar, PhD